Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)
Clinical trial NCT03061812 · COMPLETED
Trial details
- NCT number
- NCT03061812
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-11
- Primary completion
- 2020-02-12
- Enrollment
- 444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.